APA

Feng M., Wang D., Grobler J. A., Hazuda D. J., Miller M. D. & Lai M. (20160222). In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. : Antimicrobial agents and chemotherapy.

Chicago

Feng Meizhen, Wang Deping, Grobler Jay A, Hazuda Daria J, Miller Michael D and Lai Ming-Tain. 20160222. In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. : Antimicrobial agents and chemotherapy.

Harvard

Feng M., Wang D., Grobler J. A., Hazuda D. J., Miller M. D. and Lai M. (20160222). In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. : Antimicrobial agents and chemotherapy.

MLA

Feng Meizhen, Wang Deping, Grobler Jay A, Hazuda Daria J, Miller Michael D and Lai Ming-Tain. In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. : Antimicrobial agents and chemotherapy. 20160222.